Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Government Launches First UK-wide Antibody Surveillance Programme
Thousands of adults a day will be given free access to antibody tests through a […]
Health Secretary Opens New Cancer Hospital
Thousands of patients in Cumbria are set to benefit from state-of-the-art cancer diagnosis and treatment […]
First Monoclonal Antibody Treatment for COVID-19 Approved for Use in the UK
Following on from a thorough review of the evidence carried out by the MHRA, and […]
Nightlife Industry Joins Covid-19 Vaccine Push for Young People
Leading figures of the nightlife industry – including venues Ministry of Sound and Heaven – […]
NHS COVID-19 App Updated to Notify Fewer Contacts to Isolate
The public is being urged to continue to use the NHS COVID-19 app as changes […]
Fully Vaccinated Critical Workers to be Able to Leave Self-isolation in Exceptional Circumstances
Railway signallers and air traffic controllers are among the critical workers who may in exceptional […]
UK to Roll Out Biggest Flu Programme in History for Winter 2021
Millions more people could benefit from a free flu vaccine this year, as the Health […]
Almost 100% of People Have Antibodies After Second Vaccine
Imperial College London and Ipsos MORI have today published their latest antibody surveillance report showing, […]
Eight New Hospitals to be Built in England
Hundreds of thousands of people in England will benefit from new NHS facilities and services as ministers open the […]
PHE to Provide Genomic Sequencing Support to Partners Across the World
PHE Platform NVAP was announced in January by the Department of Health and Social Care […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more